Fig. 3

The relapse of patients according to MRD status after allo-HSCT. a 2-year CIR in patients without any preemptive interventions (n = 96): WT1+ alone vs. MRD-: 28.4% vs. 9.2%, P = 0.032; MRDco+ vs. MRD-: 57.1% vs. 9.2%, P < 0.001; WT1+ alone vs. MRDco+: 28.4% vs. 57.1%; P = 0.168. b 5-year CIR in all patients (n = 151): WT1+ alone vs. MRD-: 29.8% vs. 11.3%, P = 0.013; MRDco+ vs. MRD-: 55.8% vs. 11.3%, P < 0.001; WT1+ alone vs. MRDco+: 29.8% vs. 55.8%, P = 0.060